{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260624581199/en/Catalyst-Pharmaceuticals-Investor-Alert-Kahn-Swick-Foti-LLC-Investigates-Adequacy-of-Price-and-Process-in-Proposed-Sale-of-Catalyst-Pharmaceuticals-Inc.---CPRX", "message": "News view counter 814720 successfully enlarged"}